FILGRASTIM Side Effects

7014345-2 | Pruritus
on Sep 24, 2010 Female patient from UNITED STATES , 69 years of age, was diagnosed with neutropenia and was treated with Filgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus. Filgrastim dosage: 480mcg Once Sq.

6714478-1 | Febrile Neutropenia, Pulmonary Mass, Rash
Patient was taking Filgrastim (View Usage). Patient had the following side effects: febrile neutropenia, pulmonary mass, rash (What is rash?) on Apr 29, 2010 from UNITED KINGDOM Additional patient health information: Female patient , 41 years of age, . Filgrastim dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DASATINIB (View Dasatinib Review and Dasatinib Label ), FLUDARABINE PHOSPHATE (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ). Patient was hospitalized.

6675420-5 | Febrile Neutropenia, Pulmonary Mass, Rash
Adverse event was reported on Apr 01, 2010 by a Female patient taking Filgrastim (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 41 years of age, After Filgrastim was administered, patient had the following side effects: febrile neutropenia, pulmonary mass, rash (What is rash?). During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DASATINIB (View Dasatinib Review and Dasatinib Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ), IDARUBICIN HCL (View Idarubicin Hcl Review and Idarubicin Hcl Label ), IMATINIB MESYLATE (View Imatinib Mesylate Review and Imatinib Mesylate Label ). Patient was hospitalized.

6544673-6 | Interstitial Lung Disease, Pulmonary Fibrosis
on Jan 15, 2010 Male patient from UNITED KINGDOM , 39 years of age, was treated with Filgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). Filgrastim dosage: . During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.


6544672-4 | Interstitial Lung Disease, Pulmonary Fibrosis
on Jan 15, 2010 Male patient from UNITED KINGDOM , 39 years of age, was treated with Filgrastim (View Usage). Patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). Filgrastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5762360-9 | Colon Cancer, Iron Deficiency Anaemia
Patient was taking Filgrastim (View Usage). After Filgrastim was administered, patient had the following side effects: colon cancer, iron deficiency anaemia on May 28, 2008 from SPAIN Additional patient health information: Male patient , 45 years of age, weighting 147.7 lb, was diagnosed with blood stem cell harvest and. Filgrastim dosage: .

5762359-2 | Lung Cancer Metastatic
Adverse event was reported on May 28, 2008 by a Male patient taking Filgrastim (View Usage) (Dosage: ) was diagnosed with blood stem cell harvest and. Location: SPAIN , 47 years of age, Patient experienced the following unwanted or unexpected effects: lung cancer metastatic.

5762358-0 | Iron Metabolism Disorder, Myelodysplastic Syndrome, Thrombocytopenia
on May 28, 2008 Female patient from SPAIN , 65 years of age, weighting 126.8 lb, was diagnosed with blood stem cell harvest and was treated with Filgrastim (View Usage). Patient had the following side effects: iron metabolism disorder, myelodysplastic syndrome, thrombocytopenia. Filgrastim dosage: .

5443267-3 | Cardiac Output Decreased, Lactic Acidosis
on Aug 24, 2007 Male patient from UNITED KINGDOM , 78 years of age, was diagnosed with myelodysplastic syndrome and was treated with Filgrastim (View Usage). After Filgrastim was administered, patient had the following side effects: cardiac output decreased, lactic acidosis. Filgrastim dosage: . During the same period patient was treated with ATENOLOL (View Atenolol Review and Atenolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5425935-2 | Infection, Pancytopenia
Patient was taking Filgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: infection (What is infection?), pancytopenia on Aug 15, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 51 years of age, . Filgrastim dosage: . During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), FLUDARABINE (View Fludarabine Review and Fludarabine Label ).

5416685-7 | Pneumonitis, Pulmonary Fibrosis
Adverse event was reported on Aug 01, 2007 by a Male patient taking Filgrastim (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 39 years of age, Patient had the following side effects: pneumonitis, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with NEUPOGEN (View Neupogen Review and Neupogen Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

5400329-4 | Chest Discomfort, Cough, Haemoptysis, Lung Infiltration, Pulmonary Haemorrhage, Pyrexia
on Jul 18, 2007 Male patient from GERMANY , 49 years of age, was diagnosed with blood stem cell harvest and was treated with Filgrastim (View Usage). After Filgrastim was administered, patient had the following side effects: chest discomfort, cough, haemoptysis, lung infiltration, pulmonary haemorrhage, pyrexia. Filgrastim dosage: . Patient was hospitalized.

5389751-2 | Interstitial Lung Disease, Pulmonary Fibrosis
on Jul 05, 2007 Male patient from UNITED KINGDOM , 39 years of age, was treated with Filgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). Filgrastim dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ). Patient was hospitalized.

5378883-0 | Anaphylactic Reaction, Oedema Mouth, Pharyngeal Oedema, Swollen Tongue, Vomiting, Wheezing
Patient was taking Filgrastim (View Usage). Patient had the following side effects: anaphylactic reaction, oedema mouth, pharyngeal oedema, swollen tongue, vomiting, wheezing on Jun 25, 2007 from UNITED KINGDOM Additional patient health information: Female patient , weighting 133.6 lb, . Filgrastim dosage: . During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5377553-2 | Interstitial Lung Disease, Pulmonary Fibrosis
Adverse event was reported on Jun 20, 2007 by a Male patient taking Filgrastim (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 39 years of age, After Filgrastim was administered, patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ). Patient was hospitalized.

5341872-6 | Anaphylactic Reaction
on May 29, 2007 Female patient from UNITED STATES , 49 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Filgrastim (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Filgrastim dosage: 480 Mcg/ 0.8 Ml Subcutaneous Injection.

5163585-6 | Rash
on Nov 28, 2006 Male patient from UNITED STATES , 61 years of age, weighting 167.6 lb, was diagnosed with leukopenia, abscess (What is abscess?), arthritis bacterial and was treated with Filgrastim (View Usage). Patient had the following side effects: rash (What is rash?). Filgrastim dosage: 300mcg Daily Sc. During the same period patient was treated with DAPTOMYCIN (300mg Freq? Iv) (View Daptomycin Review and Daptomycin Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ).

4923293-0 | Anxiety, Back Pain, Blood Pressure Orthostatic Abnormal, Dizziness, Dyspnoea, Haematocrit Decreased, Hypoaesthesia, Laboratory Test Interference, Nausea
Patient was taking Filgrastim (View Usage). After Filgrastim was administered, patient had the following side effects: anxiety (What is anxiety?), back pain (What is back pain?), blood pressure orthostatic abnormal, dizziness (What is dizziness?), dyspnoea, haematocrit decreased, hypoaesthesia, laboratory test interference, nausea (What is nausea?) on Feb 23, 2006 from UNITED STATES Additional patient health information: Female patient , weighting 158.7 lb, was diagnosed with blood stem cell harvest and. Filgrastim dosage: 600mcg Once Sq. During the same period patient was treated with DEPO PROVERA (View Depo-provera Review and Depo-provera Label ).